Sangamo Therapeutics, Inc. , a genomic medicine company, today announced the appointment of Lisa Rojkjaer, M.D., as Chief Medical Officer. She will serve on the Executive Leadership team and report. | May 16, 2023
Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today announced the appointment of Lisa Rojkjaer, M.D., as Chief Medical Officer. She will serve on the Executive Leadership team
EagleClaw Capital Managment LLC decreased its holdings in shares of Novartis AG (NYSE:NVS – Get Rating) by 0.8% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 24,318 shares of the company’s stock after selling 200 shares during the quarter. EagleClaw […]
Community Bank & Trust Waco Texas lowered its position in Novartis AG (NYSE:NVS – Get Rating) by 6.9% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 2,698 shares of the company’s stock after selling 200 shares during the quarter. Community Bank & Trust Waco […]
Trust Co. of Vermont trimmed its holdings in Novartis AG (NYSE:NVS – Get Rating) by 5.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 62,393 shares of the company’s stock after selling 3,507 shares during the period. Trust Co. […]